Sunesis Pharmaceuticals (SNSS) Posts Smaller-than-Expected Q2 Loss
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Research and development: 6.61M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 6.61M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q2 EPS of ($0.41), $0.18 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
